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Original Article
Hepatic Epithelioid Hemangioendothelioma in
Taiwan: A Clinicopathologic Study of Six Cases in 
a Single Institution Over a 15-Year Period
Min-Shu Hsieh,1 Po-Chin Liang,2 Yu-Chien Kao,3 Chia-Tung Shun3*
Background/Purpose: Hepatic epithelioid hemangioendothelioma (HEH) is a rare vascular tumor of 
the liver typically with a slow but progressive course. We report the clinical and immunohistochemical
characteristics of six cases from our institution between 1993 and 2008.
Methods: We searched the files of the Department of Pathology in National Taiwan University Hospital
from January 1993 to December 2008 and found six cases of primary HEH. The clinical data were re-
viewed. The microscopic findings of each case were listed and analyzed. Confirmational immunoperoxi-
dase stains were performed with antibodies against two endothelial markers (CD31 and CD34) and one
epithelial marker (AE1/AE3 or cytokeratin).
Results: There were five female patients and one male patient with HEH, and the mean age was 45.3 years
(range, 25–86 years). Most patients were asymptomatic and one third of cases presented as right costal or ab-
dominal pain. Anemia was the most common laboratory abnormality. Liver failure developed at the advanced
diffuse stage. Imaging studies revealed three different patterns as single nodular, multiple nodular, or diffuse
types, reflecting different stages of disease and clinical symptoms. Microscopic findings included intracyto-
plasmic vascular lumen formation (100%), sinusoidal spreading (100%), vessel obliteration (66.7%),
necrosis (66.7%), and cellular pleomorphism (16.7%). All cases expressed endothelial markers of CD31
and CD34, reflecting their vascular nature. Two patients received surgical treatment including partial liver
resection and liver transplantation. Tumor recurrence developed 8 and 17 months later, respectively.
Conclusion: HEH showed insidious growth and frequent multicentricity, making early diagnosis and tumor
resection difficult. Definite diagnosis totally relies on pathologic study. Tumor progression to hepatic failure 
is slow. Liver transplantation is currently the most prevalent treatment modality for HEH, but experience in
Taiwan is limited due to the rarity of this disease.
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Epithelioid hemangioendothelioma (EH) is a rare
vascular tumor that was first reported by Weiss
and Enzinger in 1982.1 EH is considered to be of
endothelial origin with low- to intermediate-grade
malignancy and has a clinical behavior lying be-
tween benign hemangioma and angiosarcoma.
EH can involve soft tissue or visceral organs, in-
cluding lung, liver, spleen, or bone. The clinical
presentation of EH of the liver is nonspecific,
which makes early diagnosis difficult. Complete
tumor resection and orthotopic liver transplanta-
tion are the currently recommended treatments.
We reviewed the clinical and pathologic features of
six cases of hepatic epithelioid hemangioendothe-
lioma (HEH) in our institution during the past 15
years and discussed the behavior and treatment
of HEH, making this study the first and largest
clinicopathological study of HEH in Taiwan.
Materials and Methods
We searched and reviewed the files of the Depart-
ment of Pathology at the National Taiwan Univer-
sity Hospital from January 1993 to December
2008 and found six cases of primary HEH. Five
cases were diagnosed by liver biopsies, and one
diagnosed by tumor resection. One patient re-
ceived orthotopic liver transplantation. All speci-
mens were fixed in 10% buffered neutral formalin,
dehydrated in graded alcohol, and embedded in
paraffin blocks. The paraffin blocks were cut in
sections of 5 μm thickness, stained with hema-
toxylin and eosin, and examined by microscopy.
The immunohistochemical studies were per-
formed using the avidin-biotin-peroxidase com-
plex method2 with monoclonal antibodies against
two endothelial markers, CD31 (PECAM, Bio-
Genex, San Ramon, CA, USA) and CD34 (QBEnd/
10, Dako, Glostrup, Denmark), and one epithe-
lial marker, AE1/AE3 (4C, BioGenex, San Ramon,
CA, USA). After autoclaving for antigen retrieval,
staining was performed using a Ventana auto-
stainer (Ventana Medical Systems, Tucson, AZ,
USA) in accordance with the manufacturer’s in-
struction. Clinical data on patient age, gender,
clinical symptoms, laboratory findings, image
findings, and clinical course were obtained by
chart review. The overall survival time was esti-
mated from the date of identifying liver tumor 
to death, or the date of last follow-up.
Results
Clinical features
Clinical data from the first presentation of the 
six cases are presented in Table 1. The mean and
median ages were 45.3 and 36 years, respectively
(range, 25−86 years). The female-to-male ratio
was 5:1. Four patients were asymptomatic when
hepatic tumors were incidentally found. Among
these patients, three of them were initially diag-
nosed with hemangiomas. Increased tumor size
and numbers developed later in clinical follow-up.
One case progressed to liver failure and variceal
bleeding due to delayed diagnosis. Two sympto-
matic patients presented as right subcostal or right
upper quadrant abdominal pain, respectively. The
laboratory examinations were nonspecific and
the most common abnormality was mild ane-
mia. Only one patient with advanced disease
showed abnormal liver function tests, including
increased serum aspartate aminotransferase, ala-
nine aminotransferase, bilirubin levels and de-
creased albumin (case 4). The serum levels of
alpha fetoprotein were within normal range in all
six cases. Two cases were hepatitis B carriers and
none had chronic hepatitis C infection.
Image findings
Image findings of six cases are summarized in
Table 2. Three different patterns were identified;
single nodular, multiple nodular, or diffuse
types. Two patients (33.3%) had single nodular
lesions in the right inferior lobe (Figure 1A).
Three patients (50.0%) presented with multiple
hypodense liver nodules involving bilateral
lobes (Figure 1B). One case (16.7%) showed dif-
fuse liver involvement (Figure 1C). Increased
tumor numbers and size during follow-up were
observed.
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HEHs were often peripherally located and be-
neath the liver capsule. Surface retraction occurred
in two cases. After contrast enhancement, five
patients (83.3%) showed mild or marginal 
enhancement on the hepatic arterial (HA) phase
and increased enhancement in the portal vein (PV)
phase. One patient (case 2) showed heterogeneous
hypoenhancement on both HA and PV phases.
Table 2. Radiologic findings of six cases of hepatic epithelioid hemangioendothelioma
Case Diagnosis
Number and 
Tumor site
Contrast 
PV obliteration
Surface 
size of tumors enhancement retraction
1 CT Multiple, largest BL, confluent Hypovascular lesions Developed after  –
one: 4.1 × 2.4 cm lesions at the with peripheral 6 years follow-up
right lobe hypervascular rim
2 MRI Single, 9.0 cm, with Right IL Hypovascular, – –
satellite nodules hypodense in HA 
and PV phases
3 CT Multiple, 5 separate BL Mild enhancement on – +
masses, 2–3 cm HA to PV phase
4 CT Multiple, diffuse BL Mild enhancement on  Obliteration –
liver involvement HA, more enhancement of the left PV
on PV phase
5 CT Multiple, 4 cm BL Marginal enhancement – –
and fill-ins
6 CT Single, 2.9 cm Right IL Central enhancement on – +
delayed phase
CT = Computed tomography; MRI = magnetic resonance imaging; BL = bilateral lobes; IL = inferior lobe; HA = hepatic artery; PV = portal vein.
Table 1. Clinical and laboratory findings on first presentation of six cases of hepatic epithelioid hemangioendothelioma
Case
Age (yr)/ Initial WBC Hb Platelet AST ALT T-Bil Alb AFP HBV/
sex presentation (×103/μL) (g/dL) (× 103/μL) (U/L) (U/L) (mg/dL) (g/dL) (ng/ml) HCV
1 25/M Right subcostal 6.38 16.3 203 23 37 1.7 4.9 < 20 +/–
pain
2 86/F Right upper 8.46 11.5 232 42 26 0.6 3.4 < 5 –/–
quadrant 
abdominal pain
3 58/F Incidental 6.82 13.3 183 31 31 0.4 4.4 2.93 –/–
finding
4 31/F Incidental 4.50 10.2 158 148 118 2.2 3.7 3.35 + /–
finding*
5 36/F Incidental 4.50 9.2 287 12 13 1.2 4.5 3.02 –/–
finding
6 36/F Incidental 5.67 12.4 270 13 11 0.8 4.8 1.42 –/–
finding
*Progressed to liver failure due to delayed diagnosis. M = Male; F = female; WBC = white blood cell; Hb = hemoglobin; AST = aspartate 
aminotransferase; ALT = alanine aminotransferase; T-Bil = total bilirubin; Alb = albumin; AFP = alpha fetoprotein; HBV = hepatitis B virus;
HCV = hepatitis C virus.
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Figure 1. (A) An irregular tumor beneath the capsule at the right lobe, with central enhancement in delayed phase
(arrow). Single nodular pattern of hepatic epithelioid hemangioendothelioma, typically preferentially involved the right
lobe of the liver. (B) Multiple nodules with mild or absent enhancement were noted to be separately distributed in the
liver (arrows). One nodule showed delayed enhancement (arrowhead). This image displays the typical multiple nodular
pattern of hepatic epithelioid hemangioendothelioma. (C) Multiple small-to-large, ill-defined hypodense tumors diffusely
involved the liver parenchyma, with hypoenhancement in the hepatic artery phase. This was a typical finding for the diffuse
pattern of hepatic epithelioid hemangioendothelioma. (D) Local tumor recurrence in the liver graft. Multiple low-density
small lesions diffusely involved the liver graft. Metastatic lesion to the spleen (arrow) and the spine (inlet, arrowhead)
were also noted.
Two cases (33.3%) developed obliteration of
portal veins in advanced disease. Tumor calcifi-
cation was not found in our study.
Pathologic findings
The specimens submitted for pathologic exami-
nation included echo-guided liver biopsies in 
four cases (case 1, 2, 3, and 6), a right hepatic
lobe after right lobectomy in one case (case 5),
and a whole liver after liver transplantation in
one patient (case 4).
In case 4, where orthotopic liver transplanta-
tion was performed, the explanted, enlarged liver
showed an uneven but grossly intact capsule
(Figure 2A). When cut, most liver parenchyma
was infiltrated and replaced by ill-defined, multifo-
cal tumor masses (Figure 2B). Tumor hemorrhage
and necrosis were not grossly evident.
In the right lobe of the liver from case 5, fol-
lowing right lobectomy, six well-defined, yellow-
ish white and firm masses measuring up to
3.7 × 2.2 × 2.2 cm in size were found (Figure 2C).
These lesions were white and firm, with centrally
depressed, umbilicate surfaces (Figure 2D).
Microscopic findings and immunohistochem-
ical results are listed in Table 3. The resected liver
tumor tissue (cases 4 and 5) showed a biphasic pat-
tern composed of epithelioid cells and spindle,
Epithelioid hemangioendothelioma of liver
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Figure 2. (A) Liver specimen received after liver transplantation. The liver was enlarged with an uneven but intact cap-
sule. Multiple variable-sized yellowish white nodules were noted. (B) The cut surface of the liver showed yellowish
white, firm tumors diffusely involving the liver parenchyma, typical for the diffuse pattern stage. (C) A liver specimen re-
ceived after right lobectomy. Six separated, yellowish white nodules were found beneath the liver capsule. This pattern
clearly demonstrated the multicentric nature of hepatic epithelioid hemangioendothelioma, representing the multiple
nodular pattern. (D) The surface of the tumor was mildly elevated but centrally depressed, with an umbilicate contour
(arrow).
dendritic cells in a myxoid or fibrotic background
(Figure 3A). Characteristic intracellular lumina
were discernible in epithelioid cells. Erythrocytes
could be found inside these intracellular lumina,
suggestive of vascular differentiation. Both cases
showed ill-defined borders, grew along hepatic
sinusoids, involved contiguous parenchyma, and
obliterated terminal hepatic venules or portal vein
branches (Figure 3B). The entrapped liver plates
and bile ducts showed atrophic change eventually
replaced by tumors. In both cases, the center of
the tumor was hypocellular, densely fibrotic, and
some displayed coagulative necrosis. Cytologic
atypia featured by nuclear pleomorphism and
hyperchromatism was found in one case.
All liver tumors from small biopsies showed
scattered or confluent lesions composed of mixed
epithelioid and dendritic tumor cells in a myxo-
hyaline stroma. Tumor cells with intracytoplas-
mic lumina were easily observed. Mitotic figures
were hard to find.
Immunostaining results are shown in Table 3.
All cases were positive for the two endothelial
markers, CD31 and CD34 (Figures 3C and 3D).
The epithelioid neoplastic cells showed strong
CD31 and weak CD34 immunoreactivity. The
positive CD34 stain was restricted in the intracy-
toplasmic vascular lumen formed in tumor cells.
Cytokeratin stain was focally positive in the ep-
ithelioid cells in three cases (50%). Most of the
spindle neoplastic cells were negative for both
endothelial and cytokeratin markers. Positive
CD31 immunostaining was only found in scat-
tered spindle cells.
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Treatment and follow-up
Clinical treatment and outcomes are listed in
Table 4. The mean follow-up period is 35.2
months (ranged, 9–74 months). One patient
(case 1) died of this disease, one (case 2) died of
urosepsis, one did not attend clinical follow-ups,
and the remaining three cases are alive with this
disease.
Case 1 received transarterial embolization
(TAE) but the response was not significant. He
then quitted follow-up clinically and reappeared
with symptoms of liver failure including ascites
and jaundice 6 years later. Diffuse liver involve-
ment with thoracic spine metastasis was found
and liver transplantation was postponed. He died
2 months later due to hepatorenal syndrome.
Liver transplantation was not considered in 
case 2 because of her old age. She died 9 months 
later due to urosepsis. Case 3 received TAE but
without response. She did not follow-up after
completing pre-transplantation work up. Case 4
is the only patient who received orthotopic liver
transplantation because of liver failure and
variceal bleeding. However, tumor recurred in
the graft liver 17 months later. Case 5 received
atypical lobectomy, and local recurrence in the
left lobe was found 8 months later. Case 6 has
not yet received treatment.
Distant metastases developed in two cases
(cases 1 and 4) long after the initial diagnosis of
hepatic tumors (73 and 61 months, respectively).
The target sites of distant metastasis included the
spine and the spleen (Figure 1D).
Discussion
According to World Health Organization classifica-
tion, HEH is a tumor of variable malignant 
potential.3 The incidence rate is unknown. The
female-to-male ratio is about 3:2 in two large-
scaled studies.1,4 The clinical outcome cannot be
predicted and ranges from rapidly progressive
course to long survivors even without treatment.1
Compared with previous studies,1,4 HEHs in
our institution occurred predominantly in femaleT
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patients, with a female-to-male ratio of 5:1. The
age range was wide (25–86 years) but the major-
ity of cases were in their 3rd to 4th decades of life,
with a mean age of 45.3 years.
Early diagnosis of HEH is impeded by its in-
sidious growth, nonspecific clinical symptoms and
laboratory results. In fact, hepatic tumors were
incidentally found in two-thirds of our cases.
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Figure 3. (A) Hepatic epithelioid hemangioendothelioma showed mixed epithelioid and dendritic cells in a hyalinized, 
fibrotic background. Some epithelioid cells showed characteristic intracytoplasmic vascular lumen formation (arrows)
with erythrocytes inside the luminal space (arrowhead; hematoxylin and eosin, original magnification, 200×). (B) Liver
parenchyma was replaced by tumor cells and fibrotic stroma. The hepatic vessel in the center of the figure was nearly 
totally obliterated by tumor cells, markedly reducing the vascular caliber (arrow; hematoxylin and eosin, original magni-
fication, 40×). (C) CD31 immunostaining highlighted epithelioid cells, especially the intracytoplasmic vascular lumen 
(arrows). Most of the dendritic cells showed negative staining (arrowhead; A, B, and C, original magnification, 200×). 
(D) The epithelioid cells with intracytoplasmic lumen formation were also positive for CD34 (arrows), but were less 
intensely stained when compared with CD31 (A, B, and C, original magnification, 200×).
Table 4. Treatment and outcome of six cases of hepatic epithelioid hemangioendothelioma
Surgical Local recurrence Survival time 
Case
treatment
Distal metastasis*
(mo) (mo)/current status
1 – T-spine (73 mo) – 74, dead
2 – – – 9, dead
3 – – – 10, loss F/U
4 LT Spleen & spine (61 mo) 17, after LT 65, AWD
5 Lobectomy – 8, after lobectomy 34, AWD
6 – – – 19, AWD
*Interval from disclosure of hepatic tumor to metastasis. F/U = Follow-up; LT = liver transplantation; AWD = alive with disease.
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The radiologic findings of HEHs showed three
different patterns; single nodular (33.3%), mul-
tiple nodular (50.0%), or diffuse types (16.7%).
The single nodular type preferentially involved the
right lobe of the liver. Progressive tumor enlarge-
ment and coalescence were noted in two cases,
transforming from multiple nodular to diffuse
type HEH, thus these three patterns may represent
different stages of disease progression. Portal hy-
pertension, liver failure, ascites, jaundice, and var-
iceal bleeding were evident at the diffuse stage,
in contrast to the asymptomatic nodular stage.
HEHs have some special features visible upon
imaging, including capsular retraction, hypoen-
hancement on both HA and PV phases, and pe-
ripheral marginal or central enhancement on
delayed PV phase.5−8 These findings are distinct
from hepatocellular carcinomas, which often
show enhancement on HA phase and fading out
on PV phase.
The diagnosis of HEHs totally relies on tissue
verification. The bland-looking tumor cells and
their fibrosclerotic background simulate portal
fibrosis in small liver biopsies, especially in pa-
tients with chronic viral hepatitis. Intracytoplasmic
vascular lumina, sinusoidal tumor spreading,
obliteration of portal or central veins, and a
hyalinized, sclerotic stroma are important clues
for correct diagnosis. Immunostaining for en-
dothelial markers including CD31 and/or CD34
should be performed to confirm the diagnosis
when HEH is suspected. Mitoses and cellular
pleomorphism are unusual findings.
Differential diagnoses include cholangiocar-
cinomas, hepatocellular carcinomas, or angiosar-
comas. The first two entities often form solid
tumor masses and are composed of polygonal
tumor cells arranged in thick plates or glandular
structures and can be easily separated from HEHs
simply by microscopic examination. Positive im-
munostaining for cytokeratin, but negative stain-
ing for endothelial markers, such as CD31 or
CD34, also gives greatly assists in tumor identifi-
cation. Angiosarcomas form anastomosing vas-
cular spaces and proliferate along hepatic
sinusoids, portal or central veins. Angiosarcomas
are vascular tumors and immunoreactive to CD31
or CD34. Angiosarcomas lack single cell intracy-
toplasmic lumens or a hyalinized, sclerotic back-
ground typically presented in HEHs.9
The clinical outcome of HEH is unpredictable
and long-term survivors with stable disease have
been reported.1 Two cases in this study received
TAE but did not respond well. Patients receiving
liver transplantation and tumor resection devel-
oped local recurrence after 17 months and 8
months, respectively. There is no standard treat-
ment for HEH because of its rarity. Tumor resec-
tion is feasible in only limited cases because most
HEHs are multiple nodular or diffuse. In recent
years, most cases were treated by liver transplan-
tation.10,11 Extrahepatic tumor spread has no im-
pact on the prognosis of HEH.12−14 However, cases
with rapid tumor recurrence at liver grafts after
liver transplantation have been reported.13,15
In conclusion, HEH is a low grade malignant
vascular tumor. Early lesions tend to be single or
multiple nodules with nonspecific clinical symp-
toms. HEH should be suspected when hypovascu-
lar hepatic tumors are found in young or
middle-aged patients without previous history of
viral hepatitis. Definite diagnosis depends on
pathologic examination of biopsied or resected
specimens. Recognizing the characteristic intra-
cytoplasmic vascular lumina in epithelioid
tumor cells is important. The hypocellular, fibrotic
tumor stroma is a pitfall for misinterpretation as
portal fibrosis in chronic viral hepatitis. Combined
endothelial (CD31 and CD34) and cytokeratin
immunohistochemical stains are invaluable for
correct diagnosis.
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